Health

Philips Massager Singapore Marks a Milestone as Support Sponsor at Garmin Run Singapore 2024

SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- Philips Massager, a new category within the Royal Philips group, proudly participated as the support sponsor for the Garmin Run Singapore 2024, which took place onOctober 13 at the scenic Marina Barrage. This collaboration marked a significant milestone fo...

2024-10-30 13:27 1417

Hot from Hong Kong Fintech Week 2024: AI's Role in Transforming Insurance

SINGAPORE, Oct. 30, 2024 /PRNewswire/ -- At the 2024 Hong Kong FinTech Week InsurTech Forum,Charles Hung, CEO of Blue Insurance; Gilbert Leung, CEO of Novo AI; andPriscilla Ng, Prudential's Group Chief Customer & Marketing Officer explored the transformative role of AI in the insurance sector. Th...

2024-10-30 08:30 1559

CAS introduces stereoselective labeling in the CAS SciFinder® retrosynthesis tool - a first-of-its-kind capability in the world of scientific technology solutions

The new capability combines the industry-leading CAS Content Collection™ with cutting-edge technology and enables scientists to innovate with confidence COLUMBUS, Ohio, Oct. 29, 2024 /PRNewswire/ -- CAS, a division of the American Chemical Society specializing in scientific knowledge management, ...

2024-10-29 21:00 1269

LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement

GAITHERSBURG, Md., Oct. 29, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for i...

2024-10-29 20:30 2147

GemVax Announces Topline Results from Phase 2a Progressive Supranuclear Palsy Clinical Trial at Neuro2024

-        Topline supports moving to Phase 3 trial and shows potential to develop GV1001 as the world's first PSP treatment SEOUL, South Korea, Oct. 29, 2024 /PRNewswire/ -- GemVax & KAEL Co., Ltd. ("GemVax"; KOSDAQ ticker: 082270) announced that topline results of a Phase 2a clinical trial (the ...

2024-10-29 19:27 2171

Discovery of cancer risk associations for six novel genes

REYKJAVIK, Iceland, Oct. 29, 2024 /PRNewswire/ --Scientists at deCODE genetics/Amgen, and their collaborators have discovered six novel genes with rare germline variants that associate with cancer risk. The findings are published today in Nature Genetics under the title "Gene-based burden tests o...

2024-10-29 18:00 1371

Regional and Global Experts Convene in Accra, Ghana to Update Cancer Treatment Guidelines for Sub-Saharan Africa

Ongoing international oncology collaboration works to empower health care workers and save lives across diverse resource environments. Accra, GHANA, Oct. 29, 2024 /PRNewswire/ -- International oncology experts are gathering inAccra, Ghana for a series of meetings beginning today, to update cance...

2024-10-29 17:06 1234

Virtus Fertility Centre Singapore Expands its Medical Team with the addition of fertility specialist Dr. Tan Heng Hao.

VFCS looks to strengthen further its value of care and patients' experience with Dr. Tan's added specialty and focus on fertility treatments and minimally invasive gynaecological surgeries. SINGAPORE, Oct. 29, 2024 /PRNewswire/ -- Virtus Fertility Centre Singapore is pleased to announce that Dr....

2024-10-29 14:00 1282

The Tianqiao & Chrissy Chen Institute's OMNE Framework for Long-term AI Memory Claims Top Spot on GAIA Leaderboard

REDWOOD CITY, Calif., Oct. 29, 2024 /PRNewswire/ -- Drawing on their deep knowledge of the brain and memory, the Tianqiao & Chrissy Chen Institute's (TCCI) internal AI team achieved a major breakthrough in artificial intelligence, with their self-developed OMNE Multiagent Framework which took th...

2024-10-29 12:39 1477

RemeGen Announces the Acceptance of the Marketing Application of Telitaccept for the Treatment of Myasthenia Gravis in China

YANTAI, China, Oct. 29, 2024 /PRNewswire/ -- RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently announced that the marketing application of Taicercept ® for the treatment of generalized myasthenia gravis (gMG) has been officially...

2024-10-29 12:00 1351

The 21st World Congress of Chinese Medicine - Seminar on the Integration of Industry and Education in Cardiovascular and Cerebrovascular Diseases Kicks off in Paris

PARIS, Oct. 29, 2024 /PRNewswire/ -- On October 25, 2024, the 21st World Congress of Chinese Medicine (WCCM) commenced at the United Nations Educational, Scientific and Cultural Organization (UNESCO) Headquarters in Paris, France. A key highlight of the WCCM was the Seminar on the Integratio...

2024-10-29 11:01 1408

Blackmores Celebrates Gold Win with Trusted Brands 2024

With over 90 years of legacy, Blackmores Continues to Elevate Natural Health as one of Singaporeans' Most Trusted Health Supplement Brand SINGAPORE, Oct. 29, 2024 /PRNewswire/ -- BLACKMORES, pioneer in natural health, is proud to announce its recognition as a Gold brand in the prestigious Truste...

2024-10-29 09:00 1245

Innovent Announces Results of a Phase 2 Study of Picankibart (Anti-IL-23p19 Antibody) in Plaque Psoriasis, Showing Efficacy in Patients with Prior Inadequate Response to IL-17 Biologics

SAN FRANCISCO and SUZHOU, China, Oct. 29, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2024-10-29 07:57 1536

Asia CEO Awards Adds USANA Philippines to Their Circle of Excellence

MANILA, Philippines, Oct. 29, 2024 /PRNewswire/ -- USANA Health Sciences, Inc. and itsPhilippines market were recently added to the illustrious Circle of Excellence from the Asia CEO Awards. The Circle of Excellence recognizes the top companies inthe Philippines that have shown success and value ...

2024-10-29 07:47 1200

Clover Announces Positive Clinical Data for RSV Vaccine Candidate SCB-1019 Compared Head-to-Head Versus GSK's AREXVY

-- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) -- -- RSV neutralizing antibodies for Clover's non-adjuvanted SCB-1019 matched GSK's AS01E-adjuvanted AREXVY in older adults, while d...

2024-10-29 06:32 1394

TeleVox Applauded by Frost & Sullivan for Improving Patient Experience through Effective Engagement and Customer Value

TeleVox's highly flexible platform provides PRM capabilities covering the full extent of healthcare stakeholders, enhancing the patient population experience, decreasing missed appointments, and facilitating better care outcomes. SAN ANTONIO, Oct. 28, 2024 /PRNewswire/ -- Frost & Sullivan recentl...

2024-10-28 21:00 1210

Lilly's Mounjaro® (tirzepatide) Approved in Hong Kong in KwikPen® Presentation for Chronic Weight Management and Type 2 Diabetes, Offering a New Option for the Treatment of Obesity, Overweight and Type 2 Diabetes

* Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 * Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials6-12 * Mounjaro represents a new class of obesity and diabetes medicines and is expected to be ava...

2024-10-28 15:12 1408

/C O R R E C T I O N -- Seegene Inc./

In the news release, Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative, issued 24-Oct-2024 by Seegene Inc. over PR Newswire, we are advised by the company that the second photo and its caption should be removed as origina...

2024-10-28 12:50 3694

DKSH and FrontierView Publish Whitepaper on Southeast Asia as a Growth Accelerator for Global Healthcare Firms

DKSH and FrontierView, a business intelligence and advisory firm, published a whitepaper providing an in-depth assessment of the healthcare status of the Southeast Asia (SEA) region. The research collated in DKSH's whitepaper provides a comprehensive analysis of the regional healthcare landscape,...

2024-10-28 09:00 4138

PROVISION Study, First Ever Prospective RCT of CathWorks FFRangio Outcomes Compared to Invasive Wire-based Physiology in Japan, Meets its Primary Endpoint

PROVISION Study demonstrates significant economic and resource utilization advantages in FFRangio cohort compared to invasive wire-based FFR cohort WASHINGTON, Oct. 28, 2024 /PRNewswire/ -- Today at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) c...

2024-10-28 02:56 1241
1 ... 567891011 ... 580